Technology areas: Biotechnology & Pharmaceuticals • Chemistry & Materials
15 pending office actions • 12 art units • 15 examiners • 0 of 15 (0%) have an AI response strategy ready • 6 patents granted in the last 365 days
Kemin Industries Inc. has 15 pending office actions in Biotechnology & Pharmaceuticals. The matters involve 15 distinct examiners across 12 distinct art units, indicating a broad and distributed prosecution workload.
LOUNTOS, GEORGE THEMISTOCLIS is the busiest examiner, with 1 pending matter. Each examiner appears only once in the listed workload, so no recurring examiner relationship provides a central point for portfolio management.
The combination of examiner and art-unit dispersion calls for strong internal coordination. Counsel should standardize technical definitions, disclosure support, and amendment principles, while tailoring each response to the assigned examination group and examiner record.
Based on the USPTO statutory response window for each pending office action. 5 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 5 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (7%) |
| §103 only | 7 (47%) |
| §112 only | 3 (20%) |
| Double-patenting + other | 1 (7%) |
| Multi-statute (no §101) | 3 (20%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| LOUNTOS, GEORGE THEMISTOCLIS | 1 | 57.1% | +60.0% |
| KIM, BRYAN | 1 | 28.2% | +36.6% |
| MARTIN, PAUL C | 1 | 41.8% | +21.7% |
| BARRON, SEAN C | 1 | 52.7% | +30.4% |
| JOHNSON, DANIELLE D | 1 | 45.0% | +13.2% |
| DUBOIS, PHILIP A | 1 | 25.6% | +26.3% |
| GOTFREDSON, GAREN | 1 | 39.9% | +28.1% |
| ABBAS, ABDULRAHMAN MUSTAFA | 1 | 51.6% | +29.8% |
| DIVIESTI, KARLA ISOBEL | 1 | 3.2% | +16.7% |
| DICKENS, AMELIA NICOLE | 1 | 47.2% | +21.6% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 5 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18230227 | USE OF BETA-1,3-GLUCAN FOR MODULATING IMMUNE FUNCTION AND TREATING INTESTINAL INFLAMMATION | GOTFREDSON, GAREN | 27d |
| 18432911 | ANIMAL FEED SUPPLEMENT | DUBOIS, PHILIP A | 56d |
| 18917924 | FEED ADDITIVE FOR IMPROVING ANIMAL PERFORMANCE, DIGESTION AND INTESTINAL HEALTH AND RELATED METHODS | KIM, BRYAN | — |
| 18766645 | COMPOSITIONS CONTAINING PEROXYACIDS TO CONTROL PATHOGEN GROWTH IN ANIMAL FEED AND RELATED METHODS | JOHNSON, DANIELLE D | — |
| 18204197 | STABLE COATED CINNAMIC ALDEHYDE COMPOSITIONS FOR ANIMAL FEED AND RELATED METHODS | DIVIESTI, KARLA ISOBEL | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18211886 | INTRAOCULAR DELIVERY OF BIOACTIVE MOLECULES USING IONTOPHORESIS | ABBAS, ABDULRAHMAN MUSTAFA | 72d overdue |
| 18230227 | USE OF BETA-1,3-GLUCAN FOR MODULATING IMMUNE FUNCTION AND TREATING INTESTINAL INFLAMMATION | GOTFREDSON, GAREN | 27d |
| 18432911 | ANIMAL FEED SUPPLEMENT | DUBOIS, PHILIP A | 56d |
| 19105022 | NOVEL POLYPEPTIDE WITH GLUCANASE ACTIVITY | LOUNTOS, GEORGE THEMISTOCLIS | — |
| 18917924 | FEED ADDITIVE FOR IMPROVING ANIMAL PERFORMANCE, DIGESTION AND INTESTINAL HEALTH AND RELATED METHODS | KIM, BRYAN | — |
| 18902290 | METHODS OF ADMINISTERING COMPOSITIONS OF BACILLUS SUBTILIS PB6, BUTYRIC ACID WITH ZINC, AND OPTIONALLY RED CLOVER, TO REDUCE LIVER ABSCESSES IN CATTLE | MARTIN, PAUL C | — |
| 18794498 | METHOD AND SYSTEM FOR TREATEMNET OF MICROORGANISMS DURING PROPAGATION, CONDITIONING, FERMENTATION, AND PRESERVATION USING LAE AND SELECTED ADDITIVES | BARRON, SEAN C | — |
| 18766645 | COMPOSITIONS CONTAINING PEROXYACIDS TO CONTROL PATHOGEN GROWTH IN ANIMAL FEED AND RELATED METHODS | JOHNSON, DANIELLE D | — |
| Art Unit | Apps |
|---|---|
| 1653 | 2 |
| 1612 | 2 |
| 1652 | 1 |
| 1617 | 1 |
| 1791 | 1 |
| 1619 | 1 |
| 1792 | 1 |
| 1645 | 1 |
| 1656 | 1 |
| 1793 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19105022 | NOVEL POLYPEPTIDE WITH GLUCANASE ACTIVITY | LOUNTOS, GEORGE THEMISTOCLIS | 1652 | §112 | Non-Final OA | — | Pending | Feb 19, 2025 |
| 18917924 | FEED ADDITIVE FOR IMPROVING ANIMAL PERFORMANCE, DIGESTION AND INTESTINAL HEALTH AND RELATED METHODS | KIM, BRYAN | — | §103§112 | Non-Final OA | — | Pending | Oct 16, 2024 |
| 18902290 | METHODS OF ADMINISTERING COMPOSITIONS OF BACILLUS SUBTILIS PB6, BUTYRIC ACID WITH ZINC, AND OPTIONALLY RED CLOVER, TO REDUCE LIVER ABSCESSES IN CATTLE | MARTIN, PAUL C | 1653 | §103 | Non-Final OA | — | Pending | Sep 30, 2024 |
| 18794498 | METHOD AND SYSTEM FOR TREATEMNET OF MICROORGANISMS DURING PROPAGATION, CONDITIONING, FERMENTATION, AND PRESERVATION USING LAE AND SELECTED ADDITIVES | BARRON, SEAN C | 1653 | §103 | Final Rejection | — | Pending | Aug 05, 2024 |
| 18766645 | COMPOSITIONS CONTAINING PEROXYACIDS TO CONTROL PATHOGEN GROWTH IN ANIMAL FEED AND RELATED METHODS | JOHNSON, DANIELLE D | 1617 | §102§103§112 | Non-Final OA | — | Pending | Jul 08, 2024 |
| 18432911 | ANIMAL FEED SUPPLEMENT | DUBOIS, PHILIP A | 1791 | §103§112 | Final Rejection | 56d | Pending | Feb 05, 2024 |
| 18230227 | USE OF BETA-1,3-GLUCAN FOR MODULATING IMMUNE FUNCTION AND TREATING INTESTINAL INFLAMMATION | GOTFREDSON, GAREN | 1619 | §101DP | Non-Final OA | 27d | Pending | Aug 04, 2023 |
| 18211886 | INTRAOCULAR DELIVERY OF BIOACTIVE MOLECULES USING IONTOPHORESIS | ABBAS, ABDULRAHMAN MUSTAFA | 1612 | §103DP | Non-Final OA | 72d overdue | Pending | Jun 20, 2023 |
| 18204197 | STABLE COATED CINNAMIC ALDEHYDE COMPOSITIONS FOR ANIMAL FEED AND RELATED METHODS | DIVIESTI, KARLA ISOBEL | 1792 | §103 | Non-Final OA | — | Pending | May 31, 2023 |
| 18161617 | METHODS AND COMPOSITIONS FOR TREATING METABOLIC CONDITIONS | DICKENS, AMELIA NICOLE | 1645 | §112 | Non-Final OA | — | Pending | Jan 30, 2023 |
| 18084539 | COMPOSITIONS CONTAINING ORGANIC ACIDS AND THEIR ESTERS TO PREVENT MOLD CONTAMINATION IN ANIMAL FEED | WERTZ, ASHLEE ELIZABETH | 1612 | §103 | Non-Final OA | — | Pending | Dec 19, 2022 |
| 17974506 | COMPOSITIONS FOR INCREASING ETHANOL PRODUCTION AND RELATED METHODS | JONES-FOSTER, ERICA NICOLE | 1656 | §103 | Final Rejection | — | Pending | Oct 26, 2022 |
| 17947773 | PEA PROTEIN COMPOSITIONS FOR REDUCING FAT ABSORPTION IN FRIED FOOD AND RELATED METHODS | MORENO, LARK JULIA | 1793 | §103 | Final Rejection | — | Pending | Sep 19, 2022 |
| 17777402 | Processes for the Preparation of Alpha-Hydroxy Esters via Grignard Coupling and Thiolation Reactions | CARR, DEBORAH D | 1691 | §112 | Non-Final OA | 72d overdue | Pending | May 17, 2022 |
| 17180049 | COMPOSITIONS OF SOLUBLE BETA GLUCAN AND RELATED METHODS | CRAIGO, BAHAR ALAWI | 1699 | §103Other | Non-Final OA | 16d | Pending | Feb 19, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialKemin Industries Inc. has 15 pending office actions as of October 2026, spread across 12 art units and 15 examiners.
George Themistoclis Lountos has the most, with 1 of Kemin Industries Inc.'s pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
